As of 2024-12-12, the EV/EBITDA ratio of IDEAYA Biosciences Inc (IDYA) is -8.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IDYA's latest enterprise value is 1,949.75 mil USD. IDYA's TTM EBITDA according to its financial statements is -222.31 mil USD. Dividing these 2 quantities gives us the above IDYA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 16.5x | 15.0x |
| Forward P/E multiples | 15.0x - 17.7x | 15.8x |
| Fair Price | (34.05) - (37.71) | (34.85) |
| Upside | -225.2% - -238.7% | -228.2% |
| Date | EV/EBITDA |
| 2024-12-09 | -8.98 |
| 2024-12-06 | -9.00 |
| 2024-12-05 | -8.45 |
| 2024-12-04 | -9.22 |
| 2024-12-03 | -8.56 |
| 2024-12-02 | -8.87 |
| 2024-11-29 | -8.84 |
| 2024-11-27 | -8.69 |
| 2024-11-26 | -8.61 |
| 2024-11-25 | -8.52 |
| 2024-11-22 | -8.61 |
| 2024-11-21 | -8.54 |
| 2024-11-20 | -8.13 |
| 2024-11-19 | -8.25 |
| 2024-11-18 | -8.38 |
| 2024-11-15 | -8.56 |
| 2024-11-14 | -9.66 |
| 2024-11-13 | -10.05 |
| 2024-11-12 | -10.24 |
| 2024-11-11 | -10.63 |
| 2024-11-08 | -10.36 |
| 2024-11-07 | -9.86 |
| 2024-11-06 | -10.02 |
| 2024-11-05 | -9.70 |
| 2024-11-04 | -9.86 |
| 2024-11-01 | -9.32 |
| 2024-10-31 | -9.14 |
| 2024-10-30 | -9.65 |
| 2024-10-29 | -9.81 |
| 2024-10-28 | -9.87 |
| 2024-10-25 | -9.59 |
| 2024-10-24 | -9.55 |
| 2024-10-23 | -9.67 |
| 2024-10-22 | -9.95 |
| 2024-10-21 | -10.20 |
| 2024-10-18 | -10.07 |
| 2024-10-17 | -10.13 |
| 2024-10-16 | -10.25 |
| 2024-10-15 | -10.18 |
| 2024-10-14 | -10.05 |
| 2024-10-11 | -10.21 |
| 2024-10-10 | -9.94 |
| 2024-10-09 | -9.66 |
| 2024-10-08 | -10.27 |
| 2024-10-07 | -9.63 |
| 2024-10-04 | -9.85 |
| 2024-10-03 | -9.57 |
| 2024-10-02 | -10.52 |
| 2024-10-01 | -10.15 |
| 2024-09-30 | -10.52 |